---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-022411"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T19:30:04.612750+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical Q4 revenue $808k (+192% YoY); FY gross profit turns positive at $1.2M

## Summary
- Q4 revenue $808k, up 192% YoY; FY revenue $2.9M, up 324% YoY.
- FY gross profit $1.2M vs. gross loss ($641k) in 2022; Q4 gross margin 69%.
- Surgical procedures using Catamaran System increased 312% in FY 2023.
- Subsequent to year end: issued ~$3.85M Series A Preferred, raising $2.6M, repaid $1.25M secured debt.
- Net loss $15.6M for FY 2023 vs. $18.9M in 2022; operating loss $15.7M.

## SEC filing metadata
- accession: 0001213900-24-022411
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390024022411/0001213900-24-022411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390024022411/ea0201769-8k_tenonmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-022411
- JSON: https://secwatch.observer/filing/0001213900-24-022411.json
- Plain text: https://secwatch.observer/filing/0001213900-24-022411.txt

## Key facts
- Earnings Releases
  Tenon Medical, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $808,000 in the fourth quarter of 2023.
  - Period: the fourth quarter and full year ended December 31, 2023
  - Revenue: $808,000 in the fourth quarter of 2023
  - Result: reported results
  source text: On March 12, 2024, Tenon Medical, Inc. (the “Company”) issued a press release announcing its earnings for the fourth quarter ended December 31, 2023 and the fiscal year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1560293/000121390024022411/0001213900-24-022411-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.